Kansas ACC

@KansasACC

The Official Twitter Account of the Kansas Chapter of the American College of Cardiology.

Kansas

Joined June 2014

66Following

718Followers

Pinned

Kansas ACC@KansasACC · Jul 17

Why FACC? Because you lead the way. Join a global network shaping the future of cardiology. ow.ly/qi8e50WrgXz #FACC #CVLeadership

KansasACC's tweet image. Why FACC? Because you lead the way.
Join a global network shaping the future of cardiology.
ow.ly/qi8e50WrgXz
#FACC #CVLeadership

Kansas ACC@KansasACC · 12 h

🏆 2025 KSACC Awards – Nominations now open! Know a Kansas clinician advancing #Cardiology or heart health? Nominate now ➡️ ow.ly/6hSN50Wpjmb Deadline: Aug 1, 2025 #KSACC #HeartHealth #CVLeadership

Kansas ACC@KansasACC · Jul 25

In a nationwide Danish study (2010), SCD+ incidence was higher across all age groups—but especially elevated in those w/ prior #CVD. Risk persists. More research needed. 🔗 ow.ly/XCKW50W5Akk #JACCCEP #ACCIntl

KansasACC's tweet image. In a nationwide Danish study (2010), SCD+ incidence was higher across all age groups—but especially elevated in those w/ prior #CVD. Risk persists. More research needed.

🔗 ow.ly/XCKW50W5Akk

#JACCCEP #ACCIntl

Kansas ACC@KansasACC · Jul 24

🎧 New #ACCEL Lite episode! Drs. Roger S. Blumenthal & Christina Magnussen break down a global study that moves past a North American/European lens—translating risk into years of healthy life gained. 🌍💬 Tune in: bit.ly/4kIV0N3 #cvPrev #HeartHealth

KansasACC's tweet image. 🎧 New #ACCEL Lite episode!

Drs. Roger S. Blumenthal &amp; Christina Magnussen break down a global study that moves past a North American/European lens—translating risk into years of healthy life gained. 🌍💬

Tune in: bit.ly/4kIV0N3 #cvPrev #HeartHealth

Kansas ACC@KansasACC · Jul 22

Why FACC? Because community matters. Stay connected. Grow stronger together. ow.ly/kyX750Wrh75 #FACC #HeartHealth

Kansas ACC@KansasACC · Jul 22

Phase II trials are 🔑 for proving concept, but their limits in predicting Phase III outcomes matter. This #JACCBTS/@hfcollaboratory paper by Dr. @scottdsolomon, et al, explores improving HF trial go/no-go decisions. 🔗 ow.ly/Au0g50W5A8E

KansasACC's tweet image. Phase II trials are 🔑 for proving concept, but their limits in predicting Phase III outcomes matter. This #JACCBTS/@hfcollaboratory paper by Dr. @scottdsolomon, et al, explores improving HF trial go/no-go decisions.

🔗 ow.ly/Au0g50W5A8E

Kansas ACC@KansasACC · Jul 18

Phase 2 PURSUIT study: AZD0780 shows promising efficacy & safety, like other #PCSK9 inhibitors—plus, it's a once-daily oral option w/ statins. Ready for larger trials. 🔗 ow.ly/xUwK50W5zEv #JACC #PCSK9i

KansasACC's tweet image. Phase 2 PURSUIT study: AZD0780 shows promising efficacy &amp; safety, like other #PCSK9 inhibitors—plus, it's a once-daily oral option w/ statins. Ready for larger trials.

🔗 ow.ly/xUwK50W5zEv

#JACC #PCSK9i

Kansas ACC@KansasACC · Jul 17

Professional male bodybuilders have a significantly higher incidence of death, including a fivefold higher risk of sudden cardiac death compared with amateur bodybuilders. Learn more: bit.ly/4mBbybo #SportsCardio

Kansas ACC@KansasACC · Jul 15

Plaque progression by #YesCCT & #cvPET w/ #PCSK9i? In stable pts w/ extensive non-calcified plaque, 18 mos of evolocumab Tx lowered risk plaque & microcalcification. 🔗 ow.ly/HgFp50W5zw0 #JACCIMG #cvCAD @tamarappoo

KansasACC's tweet image. Plaque progression by #YesCCT &amp; #cvPET w/ #PCSK9i?

In stable pts w/ extensive non-calcified plaque, 18 mos of evolocumab Tx lowered risk plaque &amp; microcalcification.

🔗 ow.ly/HgFp50W5zw0

#JACCIMG #cvCAD @tamarappoo

Kansas ACC@KansasACC · Jul 14

KansasACC's tweet image. 🏆 2025 KSACC Awards – Nominations now open!
Know a Kansas clinician advancing #Cardiology or heart health?

Nominate now ➡️ ow.ly/6hSN50Wpjmb
Deadline: Aug 1, 2025

#KSACC #HeartHealth #CVLeadership

Kansas ACC@KansasACC · Jul 11

In #NSTEMI, high baseline #hsCRP was tied to pan-coronary #atherosclerosis & high-risk plaques on NIRS & #IVUS in #PROSPECTII. 🔗 ow.ly/R5hT50W5zfk #JACCINT #CardioX @FrobertOle @GreggWStone

KansasACC's tweet image. In #NSTEMI, high baseline #hsCRP was tied to pan-coronary #atherosclerosis &amp; high-risk plaques on NIRS &amp; #IVUS in #PROSPECTII.

🔗 ow.ly/R5hT50W5zfk

#JACCINT #CardioX @FrobertOle @GreggWStone

Kansas ACC@KansasACC · Jul 10

📢 KSACC invites CV professionals to submit complex cases for the 12th Annual Cardiovascular Symposium 🫀 📅 Oct 25, 2025 | 📍 Olathe, KS Submit your case: ow.ly/SiXJ50WnHlZ #KSACC #Cardiology #CasePresentation

KansasACC's tweet image. 📢 KSACC invites CV professionals to submit complex cases for the 12th Annual Cardiovascular Symposium 🫀

📅 Oct 25, 2025 | 📍 Olathe, KS
Submit your case: ow.ly/SiXJ50WnHlZ
#KSACC #Cardiology #CasePresentation

Kansas ACC@KansasACC · Jul 10

The ACC’s 🆕 “HF in a Box” toolkit is here to help clinicians elevate #HeartFailure care. 💡 Access practical tools to integrate #SGLT2 inhibitors alongside core therapies—lectures, guides, infographics & more in one place! 🔗 bit.ly/3SotOXR

KansasACC's tweet image. The ACC’s 🆕 “HF in a Box” toolkit is here to help clinicians elevate #HeartFailure care. 💡

Access practical tools to integrate #SGLT2 inhibitors alongside core therapies—lectures, guides, infographics &amp; more in one place!

🔗 bit.ly/3SotOXR

Kansas ACC@KansasACC · Jul 8

Deactivating #LVADs presents greater ethical challenges for clinicians than dialysis, a recent study finds. Important insights for those navigating advanced #HeartFailure care. 🔗 ow.ly/Waax50W5z3I #JACCAdvances #Cardiology

KansasACC's tweet image. Deactivating #LVADs presents greater ethical challenges for clinicians than dialysis, a recent study finds. Important insights for those navigating advanced #HeartFailure care.

🔗 ow.ly/Waax50W5z3I

#JACCAdvances #Cardiology

Kansas ACC@KansasACC · Jul 7

Join us Oct 5–7 in DC for the 2025 #ACC Legislative Conference—advocate for policies that shape heart care. ✔️ Hill visits ✔️ Advocacy training ✔️ National CV community Register: ow.ly/XOEt50W570i #ACC25 #Cardiology #CVAdvocacy #HeartHealth

KansasACC's tweet image. Join us Oct 5–7 in DC for the 2025 #ACC Legislative Conference—advocate for policies that shape heart care.

✔️ Hill visits
✔️ Advocacy training
✔️ National CV community

Register: ow.ly/XOEt50W570i
#ACC25 #Cardiology #CVAdvocacy #HeartHealth

Kansas ACC@KansasACC · Jul 4

In 2,853 pts w/ #Takotsubo (GEIST registry), beta-blockers were tied to ↓ follow-up mortality—but not ↓ TTS recurrence. Read the #JACCHF study: 🔗 ow.ly/VPWY50VRPgH #betablockers #TTS @S_Raposeiras #HeartFailure

KansasACC's tweet image. In 2,853 pts w/ #Takotsubo (GEIST registry), beta-blockers were tied to ↓ follow-up mortality—but not ↓ TTS recurrence.

Read the #JACCHF study:
🔗 ow.ly/VPWY50VRPgH

#betablockers #TTS @S_Raposeiras #HeartFailure

Kansas ACC@KansasACC · Jul 3

The ACC has named Viet Le, DMSc, MPAS, PA-C, FACC, to lead its #CardioSmart patient engagement program. "I'm excited to build on my predecessors' work, providing tools for informed decisions & supporting healthy life journeys." - @VietHeartPA Learn more: bit.ly/4d9hBQp

KansasACC's tweet image. The ACC has named Viet Le, DMSc, MPAS, PA-C, FACC, to lead its #CardioSmart patient engagement program. "I'm excited to build on my predecessors' work, providing tools for informed decisions &amp; supporting healthy life journeys." - @VietHeartPA

Learn more: bit.ly/4d9hBQp

Kansas ACC@KansasACC · Jul 1

🎯 #HFpEF + #Obesity + #CKD: A tough trio. #SUMMIT Trial: #Tirzepatide shows benefit, but kidney function measures raise new questions. 📈 See the nuance: 🔗 ow.ly/gjTx50VRP7t #JACC @ChrisKramerMD #CardiometabolicCare

KansasACC's tweet image. 🎯 #HFpEF + #Obesity + #CKD: A tough trio.

#SUMMIT Trial: #Tirzepatide shows benefit, but kidney function measures raise new questions.

📈 See the nuance:
🔗 ow.ly/gjTx50VRP7t

#JACC @ChrisKramerMD #CardiometabolicCare

Kansas ACC@KansasACC · Jun 27

What’s the prognostic relevance & lower limit of normal for #echofirst #GLS strain? This #JACCIMG study includes a 23K+ pt meta-analysis + 2K+ pt validation cohort. 🔗 ow.ly/IRFO50VROYm #HeartFailure @HenrykDreger #StrainImaging #CardiacFunction

KansasACC's tweet image. What’s the prognostic relevance &amp; lower limit of normal for #echofirst #GLS strain?

This #JACCIMG study includes a 23K+ pt meta-analysis + 2K+ pt validation cohort.

🔗 ow.ly/IRFO50VROYm

#HeartFailure @HenrykDreger #StrainImaging #CardiacFunction

Kansas ACC@KansasACC · Jun 26

🎥 Dive into #NCDAcademy’s Quick Access Content—short, introductory videos covering a variety of critical health topics like 🦠 flu, 🧬 metabolic diseases, 💻 digital health solutions, and more! Explore now: 🔗 bit.ly/41JXG6E #ACCIntl

KansasACC's tweet image. 🎥 Dive into #NCDAcademy’s Quick Access Content—short, introductory videos covering a variety of critical health topics like 🦠 flu, 🧬 metabolic diseases, 💻 digital health solutions, and more!

Explore now: 🔗 bit.ly/41JXG6E

#ACCIntl